Novo to launch Ozempic pill for diabetes in second quarter of this year

Core Viewpoint - Novo Nordisk plans to launch oral semaglutide for diabetes under the brand name Ozempic in the second quarter of this year [1] Company Summary - The company is expanding its product line by introducing an oral formulation of semaglutide, which is currently available in injectable form [1]